Universal access to medicines: evidence from Rajasthan, India

Simple item page
dc.contributor.authorSelvaraj, Sakthivel
dc.contributor.authorMukhopadhyay, Indranil
dc.contributor.authorKumar, Preeti
dc.contributor.authorAisola, Malini
dc.contributor.authorDatta, Pritam
dc.contributor.authorBhat, Pallav
dc.contributor.authorMehta, Aashna
dc.contributor.authorSrivastava, Swati
dc.contributor.authorPachauli, Chhaya
dc.date.accessioned2016-02-08T09:37:40Z
dc.date.available2016-02-08T09:37:40Z
dc.date.issued2014-07
dc.description.abstractIndia has outlined its commitment to achieving universal health coverage and several states in India are rolling out strategies to support this aim. In 2011, Rajasthan implemented an ambitious universal access to medicines programme based on a centralized procurement and decentralized distribution model. In terms of the three dimensions of universal health coverage, the scheme has made significant positive strides within a short period of implementation. The key objectives of this paper are to assess the likely implications of providing universal access to essential medicines in Rajasthan, which has a population of 70 million. Primary field-level data were obtained from 112 public health-care facilities using multistage random sampling. National Sample Survey Organization data and health system data were also analysed. The per capita health expenditure during the pre-reform period was estimated to be `5.7 and is now close to `50. Availability of essential medicines was encouraging and utilization of public facilities had increased. With additional per capita annual investment of `43, the scheme has brought about several improvements in the delivery of essential services and increased utilization of public facilities in the state and, as a result, enhanced efficiency of the system. Although there was an attempt to convert the scheme into a targeted one with the change in government, strong resistance from the civil society resulted in such efforts being defeated and the universality of the scheme has been retained.en_US
dc.identifier.citationWHO South-East Asia Journal of Public Health 2014;3(3&4): 289-299.en_US
dc.identifier.issn2224-3151
dc.identifier.issn2304-5272
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/172081
dc.language.isoenen_US
dc.publisherWHO Regional Office for South-East Asiaen_US
dc.source.urihttps://www.searo.who.int/publications/journals/seajph/issues/seajphv3n3p289.pdfen_US
dc.subjectdrug availabilityen_US
dc.subjectdrug stock-outsen_US
dc.subjectessential medicinesen_US
dc.subjectfinancial risk protectionen_US
dc.subjectuniversal health coverageen_US
dc.titleUniversal access to medicines: evidence from Rajasthan, Indiaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
seajph2014v3n3&4p289.pdf
Size:
1.15 MB
Format:
Adobe Portable Document Format
Description:
Policy and practice
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
WHO South-East Asia Journal of Public Health